Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061445) titled 'Study on the Clinical Course and Mechanisms of Tumor Development in Inflammatory Bowel Disease' on May 11.
Study Type:
Observational
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Ulcerative Colitis Associated Neoplasia
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to elucidate the clinical course and long term outcomes of ulcerative colitis associated neoplasia (UCAN), and to investigate its carcinogenic mechanisms through integrated endoscopic, pathological, and molecular analyses. In addition, this study aims to compare the outcomes of endoscopic and surgical treatments in order to provide evidence for optimizing surveillance and therapeutic strategies for UCAN.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 20 years or older during the study period.
Patients with gastrointestinal neoplasia associated with ulcerative colitis who underwent surgical resection or endoscopic resection.
Key exclusion criteria - Patients who opt out of participation after public disclosure of the study (by themselves or their legally authorized representatives).
Patients with insufficient clinical data or specimens for analysis.
Patients deemed inappropriate for inclusion by the principal investigator.
Target Size - 100
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 11 Month 19 Day
Date of IRB - 2025 Year 12 Month 23 Day
Anticipated trial start date - 2025 Year 11 Month 20 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070304
Disclaimer: Curated by HT Syndication.
